Clinical trials query results
From Health Canada
- Medical condition:
- MALIGNANT PLEURAL MESOTHELIOMA
- Medical condition:
- ADULT FEMALE,ADULT MALE
- Drug name:
- VS-6063
- Protocol title:
- A PHASE II RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY OF VS 6063 IN SUBJECTS WITH MALIGNANT PLEURAL MESOTHELIOMA
- Sponsor name:
- VERASTEM INCORPORATED
- Date of no objection letter:
- 2013-08-01
- Control number:
- 166217
- Trial status:
- ONGOING
- Date study started:
- 2013-07-01